Globus Medical Inc and NuVasive Inc to Create Innovative Global Musculoskeletal Company Focused on Patient Care Call Transcript
Good day, and thank you for standing by. Welcome to the Joint Globus Medical and NuVasive announcement. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Brian Kearns, Head of Investor Relations. Please go ahead.
Thank you, Victor, and thank you, everyone, for being with us this morning. Joining today's call from Globus Medical will be Dan Scavilla, President and CEO; Keith Pfeil, Chief Financial Officer; David Paul, Executive Chairman; and joining from NuVasive is Chris Barry, CEO.
This review is being made available via webcast accessible through the Investor Relations section of the Globus Medical and NuVasive websites at globusmedical.com and nuvasive.com.
Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2021 fiscal year and our subsequent filings
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |